Tapewire

Nasdaq · USD

SPRO

Spero Therapeutics, Inc.

Export transactions ↓
Tapewire entity
7014
SEC CIK
0001701108
Parsed reports
228

Last 12 months

Inside the activity.

0 purchase rows · 9 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202607
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 05, 2020 Filed Nov 7, 2020 01:48 UTC SaleCommon Stock, $0.001 par value 96,600 $13.98 $1,350,332.76
Disclosure

SEC source: 0001591986-20-000015 · primary_doc.xml · nonDerivative · entry 2

Aquilo Capital Management, LLC · CIK 0001591986 · 10% owner

Aquilo Capital, L.P. · CIK 0001491371 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 4,328,042

F1 · security: The reporting persons are Aquilo Capital, L.P. (the "Fund"), Aquilo Capital Management, LLC ("Aquilo") and Marc R. Schneidman. Aquilo is the general partner and investment adviser of the Fund and other funds managed by Aquilo that hold securities directly for the benefit of their investors. Aquilo may be deemed to beneficially own such securities indirectly as the investment adviser and general partner of the Fund and affiliated funds, and Mr. Schneidman may be deemed to beneficially own them indirectly as the control person of Aquilo. Each of Aquilo, the Fund and Mr. Schneidman disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.

F1 · ownership.nature: The reporting persons are Aquilo Capital, L.P. (the "Fund"), Aquilo Capital Management, LLC ("Aquilo") and Marc R. Schneidman. Aquilo is the general partner and investment adviser of the Fund and other funds managed by Aquilo that hold securities directly for the benefit of their investors. Aquilo may be deemed to beneficially own such securities indirectly as the investment adviser and general partner of the Fund and affiliated funds, and Mr. Schneidman may be deemed to beneficially own them indirectly as the control person of Aquilo. Each of Aquilo, the Fund and Mr. Schneidman disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.

Read SEC document
November 04, 2020 Filed Nov 6, 2020 00:00 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 7,370 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0000899243-20-030490 · doc4.xml · derivative · entry 6

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 494,809

Underlying: Common Stock · 7,370 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
November 04, 2020 Filed Nov 6, 2020 00:00 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 7,370 $14.43 $106,335.10
Disclosure

SEC source: 0000899243-20-030490 · doc4.xml · nonDerivative · entry 4

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 9,507 shares).

F4 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.25 to $14.63 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
November 04, 2020 Filed Nov 6, 2020 00:00 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 7,370 $5.90 $43,483.00
Disclosure

SEC source: 0000899243-20-030490 · doc4.xml · nonDerivative · entry 3

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,187

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 9,507 shares).

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
November 04, 2020 Filed Nov 7, 2020 01:48 UTC SaleCommon Stock, $0.001 par value 72,500 $14.26 $1,033,741.25
Disclosure

SEC source: 0001591986-20-000015 · primary_doc.xml · nonDerivative · entry 1

Aquilo Capital Management, LLC · CIK 0001591986 · 10% owner

Aquilo Capital, L.P. · CIK 0001491371 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 4,424,642

F1 · security: The reporting persons are Aquilo Capital, L.P. (the "Fund"), Aquilo Capital Management, LLC ("Aquilo") and Marc R. Schneidman. Aquilo is the general partner and investment adviser of the Fund and other funds managed by Aquilo that hold securities directly for the benefit of their investors. Aquilo may be deemed to beneficially own such securities indirectly as the investment adviser and general partner of the Fund and affiliated funds, and Mr. Schneidman may be deemed to beneficially own them indirectly as the control person of Aquilo. Each of Aquilo, the Fund and Mr. Schneidman disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.

F1 · ownership.nature: The reporting persons are Aquilo Capital, L.P. (the "Fund"), Aquilo Capital Management, LLC ("Aquilo") and Marc R. Schneidman. Aquilo is the general partner and investment adviser of the Fund and other funds managed by Aquilo that hold securities directly for the benefit of their investors. Aquilo may be deemed to beneficially own such securities indirectly as the investment adviser and general partner of the Fund and affiliated funds, and Mr. Schneidman may be deemed to beneficially own them indirectly as the control person of Aquilo. Each of Aquilo, the Fund and Mr. Schneidman disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.

Read SEC document
November 03, 2020 Filed Nov 6, 2020 00:00 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 2,137 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0000899243-20-030490 · doc4.xml · derivative · entry 5

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 502,179

Underlying: Common Stock · 2,137 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
November 03, 2020 Filed Nov 6, 2020 00:00 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 2,137 $14.27 $30,489.65
Disclosure

SEC source: 0000899243-20-030490 · doc4.xml · nonDerivative · entry 2

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 9,507 shares).

F3 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.25 to $14.35 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
November 03, 2020 Filed Nov 6, 2020 00:00 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 2,137 $5.90 $12,608.30
Disclosure

SEC source: 0000899243-20-030490 · doc4.xml · nonDerivative · entry 1

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,954

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 9,507 shares).

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
October 27, 2020 Filed Oct 27, 2020 21:37 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $13.52 $0.00
Disclosure

SEC source: 0000899243-20-029338 · doc4.xml · derivative · entry 1

FORMELA JEAN FRANCOIS · CIK 0001030575 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-10-27

F1 · derivative.exercise_date: The shares underlying this option will vest and become exercisable in full on October 27, 2021 subject to the Reporting Person's continued service as a director through the vesting date.

F2 · ownership.direct: The reporting person is a member of Atlas Venture Associates IX, LLC and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to Atlas Venture Advisors, L.P. As such, the Reporting Person disclaims beneficial ownership to the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.

Read SEC document
October 27, 2020 Filed Oct 27, 2020 21:37 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $13.52 $0.00
Disclosure

SEC source: 0000899243-20-029337 · doc4.xml · derivative · entry 1

THOMAS FRANK E · CIK 0001242616 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-10-27

F1 · derivative.exercise_date: The shares underlying this option will vest and become exercisable in full on October 27, 2021 subject to the Reporting Person's continued service as a director through the vesting date.

Read SEC document
October 27, 2020 Filed Oct 27, 2020 21:35 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $13.52 $0.00
Disclosure

SEC source: 0000899243-20-029334 · doc4.xml · derivative · entry 1

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-10-27

F1 · derivative.exercise_date: The shares underlying this option will vest and become exercisable in full on October 27, 2021 subject to the Reporting Person's continued service as a director through the vesting date.

Read SEC document
October 27, 2020 Filed Oct 27, 2020 21:34 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $13.52 $0.00
Disclosure

SEC source: 0000899243-20-029333 · doc4.xml · derivative · entry 1

Jackson Scott Thomas · CIK 0001566617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-10-27

F1 · derivative.exercise_date: The shares underlying this option will vest and become exercisable in full on October 27, 2021 subject to the Reporting Person's continued service as a director through the vesting date.

Read SEC document
October 27, 2020 Filed Oct 27, 2020 21:32 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $13.52 $0.00
Disclosure

SEC source: 0000899243-20-029329 · doc4.xml · derivative · entry 1

Deshpande Milind · CIK 0001378588 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-10-27

F1 · derivative.exercise_date: The shares underlying this option will vest and become exercisable in full on October 27, 2021 subject to the Reporting Person's continued service as a director through the vesting date.

Read SEC document
October 27, 2020 Filed Oct 27, 2020 21:31 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $13.52 $0.00
Disclosure

SEC source: 0000899243-20-029327 · doc4.xml · derivative · entry 1

VINK PATRICK V.J.J. · CIK 0001557501 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-10-27

F1 · derivative.exercise_date: The shares underlying this option will vest and become exercisable in full on October 27, 2021 subject to the Reporting Person's continued service as a director through the vesting date.

Read SEC document
October 27, 2020 Filed Oct 27, 2020 21:30 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $13.52 $0.00
Disclosure

SEC source: 0000899243-20-029326 · doc4.xml · derivative · entry 1

Pottage John C Jr · CIK 0001378587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-10-27

F1 · derivative.exercise_date: The shares underlying this option will vest and become exercisable in full on October 27, 2021 subject to the Reporting Person's continued service as a director through the vesting date.

Read SEC document
October 23, 2020 Filed Oct 27, 2020 21:32 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 20 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0000899243-20-029328 · doc4.xml · derivative · entry 3

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 504,316

Underlying: Common Stock · 20 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
October 23, 2020 Filed Oct 27, 2020 21:32 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 20 $14.25 $285.00
Disclosure

SEC source: 0000899243-20-029328 · doc4.xml · nonDerivative · entry 2

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 20 shares).

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
October 23, 2020 Filed Oct 27, 2020 21:32 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 20 $5.90 $118.00
Disclosure

SEC source: 0000899243-20-029328 · doc4.xml · nonDerivative · entry 1

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,837

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 20 shares).

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
October 14, 2020 Filed Oct 16, 2020 00:24 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 105 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0000899243-20-028430 · doc4.xml · derivative · entry 6

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 504,336

Underlying: Common Stock · 105 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
October 14, 2020 Filed Oct 16, 2020 00:24 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 105 $14.25 $1,496.25
Disclosure

SEC source: 0000899243-20-028430 · doc4.xml · nonDerivative · entry 4

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 14,472 shares).

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
October 14, 2020 Filed Oct 16, 2020 00:24 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 105 $5.90 $619.50
Disclosure

SEC source: 0000899243-20-028430 · doc4.xml · nonDerivative · entry 3

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,922

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 14,472 shares).

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
October 13, 2020 Filed Oct 16, 2020 00:24 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 14,367 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0000899243-20-028430 · doc4.xml · derivative · entry 5

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 504,441

Underlying: Common Stock · 14,367 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
October 13, 2020 Filed Oct 16, 2020 00:24 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 14,367 $14.28 $205,212.48
Disclosure

SEC source: 0000899243-20-028430 · doc4.xml · nonDerivative · entry 2

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 14,472 shares).

F3 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.25 to $14.52 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
October 13, 2020 Filed Oct 16, 2020 00:24 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 14,367 $5.90 $84,765.30
Disclosure

SEC source: 0000899243-20-028430 · doc4.xml · nonDerivative · entry 1

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,184

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 14,472 shares).

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
September 08, 2020 Filed Sep 11, 2020 01:51 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 774 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0000899243-20-024865 · doc4.xml · derivative · entry 3

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 518,808

Underlying: Common Stock · 774 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
September 08, 2020 Filed Sep 11, 2020 01:51 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 774 $14.25 $11,029.73
Disclosure

SEC source: 0000899243-20-024865 · doc4.xml · nonDerivative · entry 2

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 774 shares).

F3 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.25 to $14.26 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
September 08, 2020 Filed Sep 11, 2020 01:51 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 774 $5.90 $4,566.60
Disclosure

SEC source: 0000899243-20-024865 · doc4.xml · nonDerivative · entry 1

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,591

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 774 shares).

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
July 09, 2020 Filed Jul 9, 2020 22:48 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 2,293 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0000899243-20-018847 · doc4.xml · derivative · entry 6

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 519,582

Underlying: Common Stock · 2,293 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
July 09, 2020 Filed Jul 9, 2020 22:48 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 2,293 $14.31 $32,806.64
Disclosure

SEC source: 0000899243-20-018847 · doc4.xml · nonDerivative · entry 4

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 3,047 shares).

F4 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.25 to $14.37 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
July 09, 2020 Filed Jul 9, 2020 22:48 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 2,293 $5.90 $13,528.70
Disclosure

SEC source: 0000899243-20-018847 · doc4.xml · nonDerivative · entry 3

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,110

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 3,047 shares).

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
July 07, 2020 Filed Jul 9, 2020 22:48 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 754 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0000899243-20-018847 · doc4.xml · derivative · entry 5

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 521,875

Underlying: Common Stock · 754 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
July 07, 2020 Filed Jul 9, 2020 22:48 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 754 $14.25 $10,744.95
Disclosure

SEC source: 0000899243-20-018847 · doc4.xml · nonDerivative · entry 2

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 3,047 shares).

F3 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.25 to $14.285 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
July 07, 2020 Filed Jul 9, 2020 22:48 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 754 $5.90 $4,448.60
Disclosure

SEC source: 0000899243-20-018847 · doc4.xml · nonDerivative · entry 1

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,571

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 3,047 shares).

F2 · balance_after: Amount includes shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
June 25, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 2,642 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · derivative · entry 12

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 522,629

Underlying: Common Stock · 2,642 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 25, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 2,642 $14.25 $37,650.35
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · nonDerivative · entry 8

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 17,180 shares).

F2 · balance_after: Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
June 25, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 2,642 $5.90 $15,587.80
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · nonDerivative · entry 7

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,459

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 17,180 shares).

F2 · balance_after: Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
June 24, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 3,880 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · derivative · entry 11

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 525,271

Underlying: Common Stock · 3,880 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 24, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 3,880 $14.28 $55,419.59
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · nonDerivative · entry 6

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 17,180 shares).

F2 · balance_after: Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
June 24, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 3,880 $5.90 $22,892.00
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · nonDerivative · entry 5

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,697

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 17,180 shares).

F2 · balance_after: Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
June 23, 2020 Filed Jun 23, 2020 21:33 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $13.94 $0.00
Disclosure

SEC source: 0000899243-20-017496 · doc4.xml · derivative · entry 1

Jackson Scott Thomas · CIK 0001566617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2030-06-23

F1 · derivative.exercise_date: The shares underlying this option will vest in thirty-six equal monthly installments at the end of each successive month following June 23, 2020, subject to the Reporting Person's continued service as a director through the applicable vesting dates.

Read SEC document
June 23, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 8,045 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · derivative · entry 10

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 529,151

Underlying: Common Stock · 8,045 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 23, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 8,045 $14.33 $115,263.93
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · nonDerivative · entry 4

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 17,180 shares).

F2 · balance_after: Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
June 23, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 8,045 $5.90 $47,465.50
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · nonDerivative · entry 3

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 17,180 shares).

F2 · balance_after: Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
June 22, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 2,613 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · derivative · entry 9

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 537,196

Underlying: Common Stock · 2,613 shares

Expires 2027-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the option exercises reported herein were made with respect to options granted pursuant to the Company's 2017 Equity Incentive Plan on July 6, 2017 with vesting schedules generally consisting of 25% cliff vesting on specified dates and with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 22, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
SaleCommon Stock 2,613 $14.30 $37,364.85
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · nonDerivative · entry 2

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,817

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 17,180 shares).

F2 · balance_after: Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
June 22, 2020 Filed Jun 30, 2020 01:21 UTC
Mahadevia AnkitDirector · CEO and President
Exercise / conversionCommon Stock 2,613 $5.90 $15,416.70
Disclosure

SEC source: 0001209191-20-039352 · doc4.xml · nonDerivative · entry 1

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,430

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported on this Form 4 were made pursuant to a previously adopted Rule 10b5-1 trading plan. Specifically, the transactions reported herein relate to option exercises and related sales (totaling 17,180 shares).

F2 · balance_after: Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Read SEC document
February 03, 2020 Filed Feb 3, 2020 22:33 UTC
Melnick David A.Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $9.34 $0.00
Disclosure

SEC source: 0000899243-20-002618 · doc4.xml · derivative · entry 1

Melnick David A. · CIK 0001726485 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2030-02-03

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on February 3, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
February 03, 2020 Filed Feb 3, 2020 22:32 UTC
Mahadevia AnkitDirector · CEO and President
GrantStock Option (Right to Buy) · Derivative 180,000 $0.00 Strike: $9.34 $0.00
Disclosure

SEC source: 0000899243-20-002617 · doc4.xml · derivative · entry 1

Mahadevia Ankit · CIK 0001720974 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 180,000 shares

Expires 2030-02-03

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on February 3, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
February 03, 2020 Filed Feb 3, 2020 22:32 UTC
Larkin CristinaChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $9.34 $0.00
Disclosure

SEC source: 0000899243-20-002616 · doc4.xml · derivative · entry 1

Larkin Cristina · CIK 0001721173 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2030-02-03

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on February 3, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
February 03, 2020 Filed Feb 3, 2020 22:28 UTC
Keutzer TimothyChief Development Officer
GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $9.34 $0.00
Disclosure

SEC source: 0000899243-20-002604 · doc4.xml · derivative · entry 1

Keutzer Timothy · CIK 0001798155 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2030-02-03

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on February 3, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.